Cybin (HELP) Loans - Gross (2021 - 2023)

Cybin (HELP) posted quarterly Loans - Gross of $145.4 million for Q2 2023, up 9690639.68% on a QoQ basis from $1500.3 in Q1 2023.

Cybin (HELP) Loans - Gross (2021 - 2023) Analysis & Trends

Cybin (HELP) has reported Loans - Gross for 2 consecutive years, with $145.4 million the latest figure, recorded in Q2 2023.

Quarterly Loans - Gross changed N/A year-over-year to $145.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $145.4 million (changed N/A YoY) and the FY2023 annual result came in at $1541.7, changed N/A from the prior year.
Loans - Gross improved to $145.4 million in Q2 2023 per HELP's latest filing, from $1500.3 in the prior quarter.
Over the last five years, Loans - Gross for HELP reached as high as $145.4 million in Q2 2023 and fell as low as $1500.3 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Loans - Gross (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Cybin	28.04 Mn	28.04 Mn	-	-

Download Data